D70.1 Agranulocytosis secondary to cancer chemotherapy
Instructional Notes:
-
D70.1
Description: Agranulocytosis secondary to cancer chemotherapy
Use Additional Code:
- code for adverse effect, if applicable, to identify drug (T45.1X5)
Code Also: ['underlying neoplasm']
↓
-
D70
Description: Neutropenia
Exclude1:
- neutropenic splenomegaly (D73.81)
- transient neonatal neutropenia (P61.5)
Use Additional Code:
- code for any associated:
- fever (R50.81)
Include:
- agranulocytosis
- decreased absolute neurophile count (ANC)
Code Also: [', if applicable, mucositis (J34.81, K12.3-, K92.81, N76.81)']
↓
-
D70-D77
Description: Other disorders of blood and blood-forming organs (D70-D77)
↓
-
D50-D89
Description: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Exclude2:
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)